Necrotizing fasciitis is diagnosed through a combination of physical examination, blood tests, imaging, and ultimately surgical exploration, which remains the only definitive way to confirm the infection. Speed matters enormously: mortality rates climb from around 36% with aggressive treatment to as high as 80-100% when intervention is delayed. Because the infection spreads rapidly through tissue beneath the skin, early recognition of warning signs is the most critical step.
The Earliest Warning Sign: Pain That Doesn’t Match
The hallmark of necrotizing fasciitis in its early stages is pain that seems far worse than what the skin looks like. A patient might describe excruciating pain, but the visible area may show only mild redness, warmth, swelling, and tenderness. This mismatch, often called “pain out of proportion to exam findings,” is the single most important early clue. It happens because the infection is destroying tissue deep beneath the skin’s surface while the skin itself still looks relatively normal.
This is also what makes early diagnosis so difficult. The infection spreads through the layer of connective tissue (fascia) that sits below the skin and fat, sparing the overlying skin in the early hours. There’s often no visible trail of infection spreading outward, no swollen lymph nodes, and no red streaking along the limb. Clinicians can easily underestimate how much tissue is already involved because everything happening on the surface dramatically understates what’s going on underneath.
As the infection progresses over hours, swelling becomes firm and woody to the touch, then darkens to a deep red or purplish color. Later signs include skin color changes, blisters or fluid-filled pockets, black spots of dead skin, and pus or oozing from the area. Some people also develop dizziness, fatigue, nausea, or diarrhea as the infection triggers a systemic response. By the time these later signs appear, the infection is already advanced.
Blood Tests That Raise Suspicion
No single blood test can confirm necrotizing fasciitis, but a panel of common lab values can help distinguish it from a simpler skin infection like cellulitis. Doctors developed a scoring system called the LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis) that combines six routine blood markers into a risk assessment. The six markers it evaluates are:
- C-reactive protein (CRP): a general inflammation marker; levels at or above 150 mg/L score 4 points
- White blood cell count: elevated counts reflect the body fighting a severe infection; counts above 25 score 2 points
- Hemoglobin: low levels (below 11 g/dL) suggest the infection is destroying red blood cells or suppressing their production; scores 2 points
- Sodium: levels below 135 indicate the body is losing electrolyte balance under stress; scores 2 points
- Creatinine: elevated levels signal the kidneys are struggling, often from infection-related shock; scores 2 points
- Glucose: high blood sugar, even in non-diabetic patients, reflects a severe stress response; scores 1 point
A total score of 6 or higher raises concern. A score of 8 or above is strongly suggestive of necrotizing fasciitis. The score is useful as a screening tool, but it has limitations. Some patients with early necrotizing fasciitis score low because their bloodwork hasn’t caught up to the infection yet. A low score does not rule it out.
Another blood marker that shows promise is procalcitonin, a protein the body releases in response to bacterial infections. One study found that procalcitonin levels between roughly 5.9 and 20 had 100% accuracy in distinguishing necrotizing fasciitis from cellulitis. While this test isn’t yet part of routine protocols everywhere, it may help in ambiguous cases where the clinical picture is unclear.
What Imaging Can and Cannot Show
CT scans are the most commonly used imaging tool when necrotizing fasciitis is suspected. The key finding radiologists look for is gas within the fascial planes, which appears as small dark pockets in the tissue. When gas is present, the CT scan is quite reliable: studies show a sensitivity of about 88.5% and a specificity of about 93.3%, meaning it correctly identifies most cases and rarely gives a false alarm.
The problem is that gas in the tissue isn’t always present, especially early in the disease. A clean CT scan does not mean you’re in the clear. If the clinical picture is suspicious, meaning severe pain, rapid progression, and a toxic appearance, a normal CT should not delay surgical exploration. MRI can provide more detailed images of soft tissue inflammation, but it takes longer to perform and is less practical in an emergency setting where every hour counts.
Imaging is best understood as a supporting tool. It can strengthen a diagnosis when findings are positive, but it cannot safely exclude one when findings are negative.
Surgical Exploration: The Only Definitive Test
The gold standard for diagnosing necrotizing fasciitis is direct surgical exploration of the tissue. This involves making a small incision (roughly 2 centimeters) in the suspicious area after numbing the skin. Once the tissue is exposed, the surgeon looks for several specific signs.
Healthy tissue bleeds normally when cut. In necrotizing fasciitis, blood flow is absent or minimal because the infection has destroyed the blood vessels feeding the fascia. The surgeon also looks for a grayish, cloudy fluid sometimes described as “dishwater” in appearance, along with discolored fat that has lost its normal yellow color. The most telling part of the test is the “finger test”: the surgeon sweeps a gloved finger along the fascial layer. In healthy tissue, the fascia is tough and resists separation. In necrotizing fasciitis, the tissue falls apart with almost no resistance, like wet tissue paper pulling away from itself.
If these findings are present, the diagnosis is confirmed and the surgeon immediately proceeds to remove all the dead and infected tissue. This is why surgical exploration serves a dual purpose: it is both the most accurate diagnostic test and the beginning of treatment. Tissue samples are also sent to a lab to identify the specific bacteria involved, which helps guide antibiotic choices.
Two Types With Different Bacterial Profiles
Necrotizing fasciitis is classified into two main types based on the bacteria causing it. Type I is polymicrobial, meaning multiple types of bacteria are involved, often a mix of common gut and skin organisms. It tends to occur in people with diabetes, immune suppression, or after abdominal surgery. Type II is caused by a single organism, most commonly group A Streptococcus (the same bacteria behind strep throat). Type II can strike otherwise healthy people and tends to progress rapidly.
The type doesn’t change the urgency of diagnosis or the need for surgery, but it does affect which antibiotics are used after the bacteria are identified. In practice, broad-spectrum antibiotics are started immediately while lab results are pending, because waiting for culture results would waste critical time.
Why Speed Is Everything
The challenge with necrotizing fasciitis is that every diagnostic tool short of surgery has blind spots. Blood tests can be normal early on. Imaging can miss cases without gas formation. The physical exam can look deceptively mild. This is why clinicians are taught to treat a high index of suspicion as its own kind of evidence. If someone presents with rapidly worsening pain, swelling that’s expanding visibly over hours, fever, and a general sense of being very unwell, the threshold for surgical exploration should be low.
Mortality with modern aggressive treatment still sits between 36% and 40%. Without timely intervention, that number climbs to 80% or higher. The difference between those outcomes often comes down to how quickly someone recognizes that a “skin infection” might be something far more dangerous, and how quickly the decision is made to look beneath the surface.